Similar to these results, another report showed that pancreatic cancer cells BxPC-3, Capan-1, and PancTu-1 were unaffected by gemcitabine treatment [35], likely due to the overexpression of NF-κB by these cells. This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.